Important Questions and Answers for Investors

Investors are enabling Modular to build a for-purpose R&D and scale-up facility, and a Flexible Fermentation manufacturing facility. Modular’s demonstrated ability to design, develop, and launch new commercial products is positioning the company for an attractive exit.

What are the objectives of your Laboratory?

The laboratory and scale-up facility will use Modular’s proprietary bio-engineering platform to develop and optimize production of new biochemical products on an ongoing basis.

How can I invest in Modular's patended products?

Modular is a privately held company. Stock can only be purchased by accredited investors. Please send inquires to: investors@modulargenetics.com

What is the timeframe for your new factory?

The start of construction is subject to financing, and to completing an ongoing site search. The goal is to achieve commercial launch of AminoSurf-E in 2027.